INMED PHARMACEUTICALS INC (INM) Institutional Ownership and Insiders Activity
INMED PHARMACEUTICALS INC (INM) is widely held by institutional investors, with 15 firms reporting positions valued at approximately $8.24M based on SEC Form 13F filings for the quarter ended September 30, 2026.
Eventide Asset Management, Llc is the largest disclosed holder, reporting approximately $5.53M in INM holdings in its latest filing.
Institutional ownership remains highly concentrated, with Eventide Asset Management, Llc representing the majority of disclosed value.
Institutional Holders
15
Total Reported Value
$8.24M
Largest Holder
Eventide Asset Management, Llc
Largest Position
$5.53M
Insider Transactions (90d)
0
Latest Filing Quarter
Q3 2026
New Institutional Positions
5
Funds Exiting Positions
9
Top Institutional Owners
View allInvestorReported Balance
- Eventide Asset Management, Llc$5.53M
- Vivo Capital, Llc$1.12M
- Seven Fleet Capital Management Lp$1.00M
- Ikarian Capital, Llc$187,181
- Venrock Adviser, Llc$181,394
Related INM Institutional Insights:
- INM 13F Institutional Holders
- INM Superinvestors
- INM Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- INM Insider Trading & SEC Form 4 Activity
- INM Articles
- Top Institutional Investor Stock Rankings